Market Tracker

07/25 3:55am ET

Lannett Company Inc (NYSE:LCI)

30.67
Delayed Data
As of Jul 22
 -0.11 / -0.36%
Today’s Change
16.91
Today|||52-Week Range
60.52
-23.55%
Year-to-Date
This Simple Strategy Crushes The Irrational Market
Jul 22 / StreetAuthority - Paid Partner Content
Lannett Co. (LCI) Gets FDA Approval, Stock Soars 10.5%
Jul 11 / Zacks.com - Paid Partner Content
Why Wynn Resorts, Lannett, and Sagent Pharmaceuticals Jumped Today
Jul 11 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close30.78
Today’s open30.66
Day’s range29.94 - 30.82
Volume529,232
Average volume (3 months)954,824
Market cap$1.1B
Dividend yield--
Data as of 4:01pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+149.38%
Earnings growth (this year)-17.82%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+48.60%
P/E ratio15.3
Price/Sales5.42
Price/Book2.40

Competitors

 Today’s
change
Today’s
% change
INSYINSYS Therapeutics I...+0.33+2.11%
SRPTSarepta Therapeutics...+1.24+5.47%
DERMDermira Inc-0.29-0.91%
TBPHTheravance Biopharma...+0.66+2.96%
Data as of 07/22/2016

Financials

Next reporting dateSeptember 6, 2016
EPS forecast (this quarter)$0.60
Annual revenue (last year)$406.8M
Annual profit (last year)$149.9M
Net profit margin36.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Arthur P. Bedrosian
CFO, Treasurer &
Vice President-Finance
Martin P. Galvan
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts